Metabolic and Body Composition Changes in Ice Hockey Players Using an Ergogenic Drug (Cytoflavin)
Background and objectives: In ice hockey, the major physical workload comes from acceleration in all planes of motion and transitions between skating trajectories. Hockey players’ anthropometric characteristics correlate with performance. In team sports, the use of ergogenic drugs for recovery is re...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-01-01
|
| Series: | Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-7737/12/2/214 |
| _version_ | 1827758574944649216 |
|---|---|
| author | Victoria Zaborova Vladislav Kurshev Kira Kryuchkova Valeria Anokhina Vladimir Malakhovskiy Vera Morozova Veronika Sysoeva Giovanna Zimatore Valerio Bonavolontà Laura Guidetti Yuliya Dronina Elena Kravtsova Dmitry Shestakov Konstantin Gurevich Katie M. Heinrich |
| author_facet | Victoria Zaborova Vladislav Kurshev Kira Kryuchkova Valeria Anokhina Vladimir Malakhovskiy Vera Morozova Veronika Sysoeva Giovanna Zimatore Valerio Bonavolontà Laura Guidetti Yuliya Dronina Elena Kravtsova Dmitry Shestakov Konstantin Gurevich Katie M. Heinrich |
| author_sort | Victoria Zaborova |
| collection | DOAJ |
| description | Background and objectives: In ice hockey, the major physical workload comes from acceleration in all planes of motion and transitions between skating trajectories. Hockey players’ anthropometric characteristics correlate with performance. In team sports, the use of ergogenic drugs for recovery is relevant to avoid athletes’ overtraining. It is very important to protect athletes’ health and allow them to maintain high-performance levels. Cytoflavin is an ergogenic drug whose action is based on the combined effects of its active ingredients (succinic acid, inosine, nicotinamide and riboflavin), which are naturally occurring metabolites that stimulate tissue respiration. The study aimed to assess the 6-week Cytoflavin consumption effects on body composition (body weight, body mass index, body fat percentage and bioimpedance phase angle) and aerobic performance. Methods: This study included 60 male professional hockey players (aged 19 to 36 years) divided into two groups of 30 subjects: group I (body weight 87.90 ± 7.44 kg, BMI 25.86 ± 2.04 kg/m<sup>2</sup>) and group II (body weight 87.04 ± 6.22 kg, BMI 25.52 ± 2.38 kg/m<sup>2</sup>). Athletes in group I received Cytoflavin, whereas athletes in group II did not. Results: In group I, statistically significant reductions in body weight and body mass index were not observed until 14 and 35 days, respectively. In contrast, in group II, both body weight and BMI significantly decreased both times. Aerobic performance significantly increased in both groups, with significantly greater increases in group I. Conclusions: Cytoflavin can be considered an ergogenic drug that improves body composition parameters, especially in the control of weight reduction and improvement in aerobic performance. |
| first_indexed | 2024-03-11T09:08:21Z |
| format | Article |
| id | doaj.art-c1b03374553448a5973e6b596fec12f5 |
| institution | Directory Open Access Journal |
| issn | 2079-7737 |
| language | English |
| last_indexed | 2024-03-11T09:08:21Z |
| publishDate | 2023-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biology |
| spelling | doaj.art-c1b03374553448a5973e6b596fec12f52023-11-16T19:13:13ZengMDPI AGBiology2079-77372023-01-0112221410.3390/biology12020214Metabolic and Body Composition Changes in Ice Hockey Players Using an Ergogenic Drug (Cytoflavin)Victoria Zaborova0Vladislav Kurshev1Kira Kryuchkova2Valeria Anokhina3Vladimir Malakhovskiy4Vera Morozova5Veronika Sysoeva6Giovanna Zimatore7Valerio Bonavolontà8Laura Guidetti9Yuliya Dronina10Elena Kravtsova11Dmitry Shestakov12Konstantin Gurevich13Katie M. Heinrich14Institute of Clinical Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, RussiaInstitute of Clinical Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, RussiaInstitute of Clinical Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, RussiaInstitute of Clinical Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, RussiaInstitute of Clinical Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, RussiaInstitute of Clinical Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, RussiaInstitute of Clinical Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, RussiaDepartment of Theoretical and Applied Sciences, eCampus University, 22060 Novedrate, ItalyDepartment of Biotechnological and Applied Clinical Sciences University of L’Aquila, 67100 L’Aquila, ItalyUnicusano Department, Università Niccolò Cusano, 00166 Rome, ItalyInstitute of Public Health, Sechenov First Moscow State Medical University, 119991 Moscow, RussiaInstitute of Public Health, Sechenov First Moscow State Medical University, 119991 Moscow, RussiaMoscow Clinical Scientific Center named after A. S. Loginov, 111123 Moscow, RussiaUNESCO Chair, A.I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, RussiaDepartment of Kinesiology, Kansas State University, Manhattan, KS 66506, USABackground and objectives: In ice hockey, the major physical workload comes from acceleration in all planes of motion and transitions between skating trajectories. Hockey players’ anthropometric characteristics correlate with performance. In team sports, the use of ergogenic drugs for recovery is relevant to avoid athletes’ overtraining. It is very important to protect athletes’ health and allow them to maintain high-performance levels. Cytoflavin is an ergogenic drug whose action is based on the combined effects of its active ingredients (succinic acid, inosine, nicotinamide and riboflavin), which are naturally occurring metabolites that stimulate tissue respiration. The study aimed to assess the 6-week Cytoflavin consumption effects on body composition (body weight, body mass index, body fat percentage and bioimpedance phase angle) and aerobic performance. Methods: This study included 60 male professional hockey players (aged 19 to 36 years) divided into two groups of 30 subjects: group I (body weight 87.90 ± 7.44 kg, BMI 25.86 ± 2.04 kg/m<sup>2</sup>) and group II (body weight 87.04 ± 6.22 kg, BMI 25.52 ± 2.38 kg/m<sup>2</sup>). Athletes in group I received Cytoflavin, whereas athletes in group II did not. Results: In group I, statistically significant reductions in body weight and body mass index were not observed until 14 and 35 days, respectively. In contrast, in group II, both body weight and BMI significantly decreased both times. Aerobic performance significantly increased in both groups, with significantly greater increases in group I. Conclusions: Cytoflavin can be considered an ergogenic drug that improves body composition parameters, especially in the control of weight reduction and improvement in aerobic performance.https://www.mdpi.com/2079-7737/12/2/214ice hockey playersCytoflavinbody compositionbioelectrical impedance analysisaerobic fitnessovertraining |
| spellingShingle | Victoria Zaborova Vladislav Kurshev Kira Kryuchkova Valeria Anokhina Vladimir Malakhovskiy Vera Morozova Veronika Sysoeva Giovanna Zimatore Valerio Bonavolontà Laura Guidetti Yuliya Dronina Elena Kravtsova Dmitry Shestakov Konstantin Gurevich Katie M. Heinrich Metabolic and Body Composition Changes in Ice Hockey Players Using an Ergogenic Drug (Cytoflavin) Biology ice hockey players Cytoflavin body composition bioelectrical impedance analysis aerobic fitness overtraining |
| title | Metabolic and Body Composition Changes in Ice Hockey Players Using an Ergogenic Drug (Cytoflavin) |
| title_full | Metabolic and Body Composition Changes in Ice Hockey Players Using an Ergogenic Drug (Cytoflavin) |
| title_fullStr | Metabolic and Body Composition Changes in Ice Hockey Players Using an Ergogenic Drug (Cytoflavin) |
| title_full_unstemmed | Metabolic and Body Composition Changes in Ice Hockey Players Using an Ergogenic Drug (Cytoflavin) |
| title_short | Metabolic and Body Composition Changes in Ice Hockey Players Using an Ergogenic Drug (Cytoflavin) |
| title_sort | metabolic and body composition changes in ice hockey players using an ergogenic drug cytoflavin |
| topic | ice hockey players Cytoflavin body composition bioelectrical impedance analysis aerobic fitness overtraining |
| url | https://www.mdpi.com/2079-7737/12/2/214 |
| work_keys_str_mv | AT victoriazaborova metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT vladislavkurshev metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT kirakryuchkova metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT valeriaanokhina metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT vladimirmalakhovskiy metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT veramorozova metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT veronikasysoeva metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT giovannazimatore metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT valeriobonavolonta metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT lauraguidetti metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT yuliyadronina metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT elenakravtsova metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT dmitryshestakov metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT konstantingurevich metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin AT katiemheinrich metabolicandbodycompositionchangesinicehockeyplayersusinganergogenicdrugcytoflavin |